Comments
Loading...

Sanofi Analyst Ratings

SNYNASDAQ
Logo brought to you by Benzinga Data
$55.82
0.911.66%
At close: -
$57.69
1.873.35%
After Hours: 7:12 PM EDT
Consensus Rating1
Neutral
Highest Price Target1
$65.00
Lowest Price Target1
$55.00
Consensus Price Target1
$60.00

Sanofi Analyst Ratings and Price Targets | NASDAQ:SNY | Benzinga

Sanofi SA has a consensus price target of $60 based on the ratings of 4 analysts. The high is $65 issued by Goldman Sachs on March 21, 2025. The low is $55 issued by Morgan Stanley on January 23, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, Argus Research, and Morgan Stanley on March 21, 2025, July 26, 2024, and January 23, 2024, respectively. With an average price target of $60 between Goldman Sachs, Argus Research, and Morgan Stanley, there's an implied 4.00% upside for Sanofi SA from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.3
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Goldman Sachs
Argus Research
Morgan Stanley

1calculated from analyst ratings

Analyst Ratings for Sanofi

Buy NowGet Alert
03/21/2025Buy Now12.67%Goldman Sachs
James Quigley26%
→ $65Initiates → NeutralGet Alert
07/26/2024Buy Now4%Argus Research
Jasper Hellweg69%
$55 → $60MaintainsBuyGet Alert
01/23/2024Buy Now-4.66%Morgan Stanley
Mark Purcell30%
→ $55Initiates → Equal-WeightGet Alert
03/27/2023Buy Now4%Argus Research
Jasper Hellweg69%
$55 → $60MaintainsBuyGet Alert
08/12/2022Buy NowDeutsche Bank
Emmanuel Papadakis47%
UpgradeSell → HoldGet Alert

FAQ

Q

What is the target price for Sanofi (SNY) stock?

A

The latest price target for Sanofi (NASDAQ:SNY) was reported by Goldman Sachs on March 21, 2025. The analyst firm set a price target for $65.00 expecting SNY to rise to within 12 months (a possible 12.67% upside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Sanofi (SNY)?

A

The latest analyst rating for Sanofi (NASDAQ:SNY) was provided by Goldman Sachs, and Sanofi initiated their neutral rating.

Q

When was the last upgrade for Sanofi (SNY)?

A

The last upgrade for Sanofi SA happened on August 12, 2022 when Deutsche Bank raised their price target to N/A. Deutsche Bank previously had a sell for Sanofi SA.

Q

When was the last downgrade for Sanofi (SNY)?

A

There is no last downgrade for Sanofi.

Q

When is the next analyst rating going to be posted or updated for Sanofi (SNY)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sanofi, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sanofi was filed on March 21, 2025 so you should expect the next rating to be made available sometime around March 21, 2026.

Q

Is the Analyst Rating Sanofi (SNY) correct?

A

While ratings are subjective and will change, the latest Sanofi (SNY) rating was a initiated with a price target of $0.00 to $65.00. The current price Sanofi (SNY) is trading at is $57.69, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch